152 related articles for article (PubMed ID: 9869179)
21. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE).
Patri S; Salmeron S; Caillon M; Kitzis A; Chomel JC
Thromb Haemost; 1999 Feb; 81(2):313-4. PubMed ID: 10064013
[No Abstract] [Full Text] [Related]
22. Prevalence of the prothrombin gene 20210A mutation in thrombophilic and healthy Algerian subjects.
Helley D; Chafa O; Yaker NL; Reghis A; Fischer AM
Thromb Haemost; 1999 Nov; 82(5):1554-5. PubMed ID: 10595654
[No Abstract] [Full Text] [Related]
23. Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.
Souto JC; Mateo J; Soria JM; Llobet D; Coll I; Borrell M; Fontcuberta J
Haematologica; 1999 Jul; 84(7):627-32. PubMed ID: 10406905
[TBL] [Abstract][Full Text] [Related]
24. The 677C-->T mutation of the methylene-tetrahydrofolate reductase gene in the pathogenesis of osteonecrosis of the femoral head.
Zalavras CG; Malizos KN; Dokou E; Vartholomatos G
Haematologica; 2002 Jan; 87(1):111-2. PubMed ID: 11801474
[No Abstract] [Full Text] [Related]
25. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism in a young woman with combined homozygosity for factor V Leiden and prothrombin G20210A mutations.
Leonard M; Gala JL; Verschuren F; Coche E; Deneys V; Hainaut P
Haematologica; 2005 Nov; 90 Suppl():ECR30. PubMed ID: 16266921
[No Abstract] [Full Text] [Related]
28. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
[TBL] [Abstract][Full Text] [Related]
29. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome.
Burzotta F; Leone AM; Paciaroni K; De Stefano V; Rossi E; Testa L; Giannico F; Leone G; Maseri A; Crea F; Andreotti F
Haematologica; 2004 Sep; 89(9):1134-8. PubMed ID: 15377476
[TBL] [Abstract][Full Text] [Related]
30. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
31. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population.
Lu Y; Zhao Y; Liu G; Wang X; Liu Z; Chen B; Hui R
Thromb Res; 2002 Apr; 106(1):7-12. PubMed ID: 12165282
[TBL] [Abstract][Full Text] [Related]
32. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
[TBL] [Abstract][Full Text] [Related]
33. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
[TBL] [Abstract][Full Text] [Related]
34. [Prevalence of factor V Leiden, hyperhomocysteinemia, prothrombin G20210A, and methylene tetrahydrofolate reductase C677T mutations in obstetrical complications].
Verdy E; Berkane N; Magdelaine A; Soubrier F; Uzan S
Ann Biol Clin (Paris); 1999; 57(5):539-44. PubMed ID: 10518055
[TBL] [Abstract][Full Text] [Related]
35. A patient homozygous for mutation 20210A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin.
González Ordóñez AJ; Medina Rodriguez JM; Fernández Alvarez CR; Macias Robles MD; Coto García E
Haematologica; 1998 Nov; 83(11):1050-1. PubMed ID: 9864932
[TBL] [Abstract][Full Text] [Related]
36. The C677T MTHFR variant and the risk of venous thrombosis.
Salden A; Keeney S; Hay CR; Cumming AM
Br J Haematol; 1997 Nov; 99(2):472. PubMed ID: 9375781
[No Abstract] [Full Text] [Related]
37. Embryo implantation after assisted reproductive procedures and maternal thrombophilia.
Martinelli I; Taioli E; Ragni G; Levi-Setti P; Passamonti SM; Battaglioli T; Lodigiani C; Mannucci PM
Haematologica; 2003 Jul; 88(7):789-93. PubMed ID: 12857558
[TBL] [Abstract][Full Text] [Related]
38. Sudden infant death syndrome, childhood thrombosis, and presence of genetic risk factors for thrombosis.
Larsen TB; Nørgaard-Pedersen B; Lundemose JB; Rüdiger N; Gaustadnes M; Brandslund I
Thromb Res; 2000 May; 98(4):233-9. PubMed ID: 10822069
[TBL] [Abstract][Full Text] [Related]
39. Thrombophilic mutations impart a high risk of pregnancy-related venous thrombosis.
Press RD
Mol Diagn; 2000 Jun; 5(2):158. PubMed ID: 11066018
[No Abstract] [Full Text] [Related]
40. Factor V Leiden mutation in women with idiopathic pulmonary embolism.
Andersen BS; Olsen J
Thromb Haemost; 1997 Oct; 78(4):1298. PubMed ID: 9365004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
